Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray

Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray

Item
http://www.wikidata.org/entity/Q33606254
Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 GenesClinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinomaAndrogen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration.B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells.CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.Estrogen receptor prevents p53-dependent apoptosis in breast cancer.p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferationEndogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients.Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.Analysis of protein biomarkers in human clinical tumor samples: critical aspects to success from tissue acquisition to analysis.The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells.MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.Induction of DNA damage signaling genes in benzidine-treated HepG2 cells.
P2860

Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray

Item
http://www.wikidata.org/entity/Q33606254
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Up-regulation of cell cycle ar ...... mistry using tissue microarray
@ast
Up-regulation of cell cycle ar ...... mistry using tissue microarray
@en
type
label
Up-regulation of cell cycle ar ...... mistry using tissue microarray
@ast
Up-regulation of cell cycle ar ...... mistry using tissue microarray
@en
prefLabel
Up-regulation of cell cycle ar ...... mistry using tissue microarray
@ast
Up-regulation of cell cycle ar ...... mistry using tissue microarray
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Up-regulation of cell cycle ar ...... mistry using tissue microarray
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P921
P932